Pulmonary Cryptococcosis in the Immunocompetent Patient—Many Questions, Some Answers

Background. There are no prospective data regarding the management of pulmonary cryptococcosis in the immunocompetent patient. Clinical guidelines recommend oral fluconazole for patients with mild to moderate symptoms and amphotericin B plus flucytosine followed by fluconazole for severe disease. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, John F., Valencia-Rey, Paula A., Davis, William B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047412/
https://www.ncbi.nlm.nih.gov/pubmed/27704021
http://dx.doi.org/10.1093/ofid/ofw167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047412/
https://www.ncbi.nlm.nih.gov/pubmed/27704021
http://dx.doi.org/10.1093/ofid/ofw167

Ejemplares similares